Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-11-13
1987-09-08
Rizzo, Nicholas S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546101, A61K 3147, C07D22108
Patent
active
046924531
ABSTRACT:
A 6- or 8-monooxy- or 6,8-dioxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline in which the 3-position is unsubstituted, is useful as a pharmaceutical, in particular as a prolactin secretion inhibitor, dopaminergic agent and dopamine receptor stimulating agent.
REFERENCES:
patent: 3639411 (1972-02-01), Alberston et al.
patent: 3839338 (1974-10-01), Albertson et al.
patent: 3898235 (1975-08-01), Albertson et al.
patent: 4565818 (1986-01-01), Nordmann et al.
Walsh et al., J. Org. Chem., vol. 39, No. 25, pp. 3705-3708 (1974).
Cannon et al., Chemical Abstracts, vol. 92, 51846n (1980).
Cannon et al., Chemical Abstracts vol. 94, 83909t (1981).
Costall et al., Chemical Abstracts, vol. 95, 161968y (1981).
Cannon et al., Chemical Abstracts, vol. 96, 6539m (1982).
Maixner et al., Chemical Abstracts, vol. 98, 172567e (1983).
Cannon et al., Chemical Abstracts, vol. 100, 51426j (1984).
Honor Robert S.
McGovern Thomas O.
Rivers Diana G.
Rizzo Nicholas S.
Sandoz Ltd.
LandOfFree
Pharmaceutical active 1,2,3,4,4A,5,10,10A-octahydrobenzo[g] quin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical active 1,2,3,4,4A,5,10,10A-octahydrobenzo[g] quin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical active 1,2,3,4,4A,5,10,10A-octahydrobenzo[g] quin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2158471